Phase 3CompletedINTERVENTIONAL
The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
ClinicalTrials.gov · NCT00856609 · Registry updated: 2019-06-04
- Condition / research focus
- Weight Loss; Obesity
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2009-03-03. Completion: 2016-09-19 (may be estimated). Results are posted in this registry.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Byetta (exenatide) (drug)
- Weight loss (behavioral)
- Metabolic Chamber (other)
- Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Phoenix, Arizona, United States